PFIZER

NYSE
PFE
Stock
Yield per half year: -2.25%
Dividend yield: 6.49%
Sector: Healthcare

PFIZER

33.0033.0030.0030.0027.0027.0024.0024.0021.0021.00Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
7/10
18.75 52.65 -64.38% 29.91 -37.3%
P/S 2.37 4.03 -41.24%
P/BV 1.7 10.86 -84.33%
P/FCF 21.05 39.64 -46.91%
Ev/Ebitda 11.76 16.29 -27.8%
Ev/S 3.35 4.35 -22.91%
Ev/FCF 21.68 52.22 -58.48%
E/P 0.0388 0.2095 -81.48%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
28.49 18.92 50.57% 29.86 -4.6%
ROE 9.06 -83.32 -110.88%
ROA 3.65 6.38 -42.76%
ROIC 23.27 15.07 54.46%
ROS 12.62 9.34 35.21%
ROCE 6.52 84.77 -92.31%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
3/10
3.51 1.04 238.21% 3.41 +3%
Nеt Debt/Ebitda 3.45 1.42 143.49%
Debt/Ratio 0.2983 0.2741 8.82%
Debt/Equity 0.7216 15.68 -95.4%
Debt/Net Income 7.93 6.8 16.57%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
10/10
6.49 1.28 405.07% 5.1 +27.17%
Number of years of dividend growth 11 6.75 63.06%
DSI 1 0.7413 34.89%
Average dividend growth 3.95 -4.1 -196.33%
Average percentage for 5 years 5.1 1.34 282.26%
Average percentage for payments 74.01 44.08 67.88%
Difference from average difference in sector 5.21

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
7/10
51.82 54.39 -4.73%
Growth impulse Ebitda in 5 years 28.83 -89.73 -132.13%
Growth impulse Net Income in 5 years 14.4 -83.26 -117.3%
Growth impulse FCF in 5 years -15.29 -81.95 -81.34%
Growth impulse EPS in 5 years 12.72 39.71 -67.97%
IP Score
5.92/10

Similar companies

AbbVie

Eli Lilly and Company

Johnson & Johnson

Zoetis

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription